T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
CorVel
CRVL
$3.17B
| $20.2M | ﹤0.01% |
1,110,285
+42,360
| +4% | +$1.1M |
|
1077
Ameris Bancorp
ABCB
$5.94B
| $20.1M | ﹤0.01% |
847,729
-96,181
| -10% | -$3.43M |
|
1078
Masco
MAS
$14.7B
| $20.1M | ﹤0.01% |
581,055
+45,748
| +9% | +$2M |
|
1079
James River Group Holdings
JRVR
$199M
| $19.9M | ﹤0.01% |
547,912
-225,420
| -29% | -$9.08M |
|
|
HDS
1080
DELISTED
HD Supply Holdings, Inc.
HDS
| $19.7M | ﹤0.01% |
693,433
+5,206
| +0.8% | +$194K |
|
1081
Genuine Parts
GPC
$18.5B
| $19.6M | ﹤0.01% |
291,767
+20,062
| +7% | +$1.79M |
|
|
DCUE
1082
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $19.6M | ﹤0.01% |
+209,251
| New | +$21.8M |
|
1083
Fate Therapeutics
FATE
$317M
| $19.5M | ﹤0.01% |
878,963
-103,618
| -11% | -$2.62M |
|
1084
Main Street Capital
MAIN
$5.47B
| $19.5M | ﹤0.01% |
949,145
+28,284
| +3% | +$1.06M |
|
1085
Hasbro
HAS
$13.4B
| $19.4M | ﹤0.01% |
271,568
+27,800
| +11% | +$2.41M |
|
|
CMD
1086
DELISTED
Cantel Medical Corporation
CMD
| $19.2M | ﹤0.01% |
535,565
-57,397
| -10% | -$3.26M |
|
1087
Stepan Co
SCL
$1.48B
| $19.2M | ﹤0.01% |
216,795
-4,104
| -2% | -$392K |
|
1088
Qorvo
QRVO
$8.67B
| $19.2M | ﹤0.01% |
237,840
+17,471
| +8% | +$1.75M |
|
1089
NetApp
NTAP
$39.6B
| $19.1M | ﹤0.01% |
459,010
+34,605
| +8% | +$1.79M |
|
|
UFS
1090
DELISTED
DOMTAR CORPORATION (New)
UFS
| $19.1M | ﹤0.01% |
881,297
+559,067
| +173% | +$17.8M |
|
1091
First Hawaiian
FHB
$3.36B
| $19M | ﹤0.01% |
1,150,814
+92,771
| +9% | +$2.34M |
|
1092
Guidewire Software
GWRE
$14.4B
| $19M | ﹤0.01% |
239,355
-936,610
| -80% | -$97.8M |
|
|
HBMD
1093
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $18.9M | ﹤0.01% |
1,741,820
+56,329
| +3% | +$878K |
|
1094
Hubbell
HUBB
$27.1B
| $18.9M | ﹤0.01% |
164,563
-40,384
| -20% | -$5.45M |
|
1095
Oneok
OKE
$58.3B
| $18.9M | ﹤0.01% |
865,305
+69,212
| +9% | +$4.22M |
|
1096
RH
RH
$3.41B
| $18.8M | ﹤0.01% |
186,782
-3,336
| -2% | -$622K |
|
|
CYBR
1097
DELISTED
CyberArk
CYBR
| $18.8M | ﹤0.01% |
219,165
-49,123
| -18% | -$5.66M |
|
|
CHCT
1098
Community Healthcare Trust
CHCT
$430M
| $18.7M | ﹤0.01% |
488,778
+4,861
| +1% | +$211K |
|
|
VAR
1099
DELISTED
Varian Medical Systems, Inc.
VAR
| $18.6M | ﹤0.01% |
181,199
+14,326
| +9% | +$1.89M |
|
1100
Devon Energy
DVN
$48.8B
| $18.5M | ﹤0.01% |
2,681,640
-4,600,197
| -63% | -$83.2M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.